PLEXAPR-B Trademark

Trademark Overview

On Friday, July 17, 2020, a trademark application was filed for PLEXAPR-B with the United States Patent and Trademark Office. The USPTO has given the PLEXAPR-B trademark a serial number of 90057724. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 16, 2021. This trademark is owned by PLEXISION,INC. The PLEXAPR-B trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical research in the field of antigen presentation of B Cells
plexapr-b

General Information

Serial Number90057724
Word MarkPLEXAPR-B
Filing DateFriday, July 17, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 16, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2020

Trademark Statements

Goods and ServicesClinical research in the field of antigen presentation of B Cells

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 14, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePLEXISION,INC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15224
Party NamePLEXISION,INC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15224

Trademark Events

Event DateEvent Description
Wednesday, September 29, 2021WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, September 29, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, August 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 16, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 16, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 28, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 5, 2020EXAMINER'S AMENDMENT ENTERED
Monday, October 5, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 5, 2020EXAMINERS AMENDMENT E-MAILED
Monday, October 5, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, October 2, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 2, 2020NON-FINAL ACTION E-MAILED
Friday, October 2, 2020NON-FINAL ACTION WRITTEN
Tuesday, September 29, 2020ASSIGNED TO EXAMINER
Friday, August 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 21, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

plexapr presentation cells antigen field research clinical